Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Neuro-Oncology Advances
|
March 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas
Solmaz Sahebjam, Raju R Raval, Peter A Forsyth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 20, 2023
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies
Benedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, et al.
Neuro-Oncology
|
April 6, 2021
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience
Eudocia Q Lee, Wendy Selig, Clair Meehan, et al.
Neuro-Oncology Advances
|
April 25, 2025
Consortium for Intracranial Metastasis Academic Research (CIMARa): Global interdisciplinary collaborations to improve outcomes of patient with brain metastases
Carey K Anders, Amanda E D Van Swearingen, Josh Neman, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2025
Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee
Jennifer Dent, Micaella Jorge, Nora Sobrevilla, et al.
Research Square
|
February 15, 2023
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial
Amanda L King, Kayla N Roche, Heather E Leeper, et al.
Neuro-Oncology
|
November 11, 2020
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study
Solmaz Sahebjam, Peter A Forsyth, Nam D Tran, et al.
Advances in Radiation Oncology
|
December 22, 2021
Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study
Kamran A Ahmed, Youngchul Kim, John A Arrington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma
Kirit Singh, Kristen A Batich, Patrick Y Wen, et al.
Neuro-Oncology
|
January 25, 2020
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients
Eudocia Q Lee, Michael Weller, Joohee Sul, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Neuro-Oncology Advances
|
March 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas
Solmaz Sahebjam, Raju R Raval, Peter A Forsyth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 20, 2023
Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies
Benedito A Carneiro, Ludimila Cavalcante, Devalingam Mahalingam, et al.
Neuro-Oncology
|
April 6, 2021
Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience
Eudocia Q Lee, Wendy Selig, Clair Meehan, et al.
Neuro-Oncology Advances
|
April 25, 2025
Consortium for Intracranial Metastasis Academic Research (CIMARa): Global interdisciplinary collaborations to improve outcomes of patient with brain metastases
Carey K Anders, Amanda E D Van Swearingen, Josh Neman, et al.
Journal for Immunotherapy of Cancer
|
June 23, 2025
Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee
Jennifer Dent, Micaella Jorge, Nora Sobrevilla, et al.
Research Square
|
February 15, 2023
Feasibility of a virtual reality intervention targeting distress and anxiety symptoms in patients with primary brain tumors: Interim analysis of a phase 2 clinical trial
Amanda L King, Kayla N Roche, Heather E Leeper, et al.
Neuro-Oncology
|
November 11, 2020
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study
Solmaz Sahebjam, Peter A Forsyth, Nam D Tran, et al.
Advances in Radiation Oncology
|
December 22, 2021
Nivolumab and Stereotactic Radiosurgery for Patients With Breast Cancer Brain Metastases: A Nonrandomized, Open-Label Phase 1b Study
Kamran A Ahmed, Youngchul Kim, John A Arrington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2021
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma
Kirit Singh, Kristen A Batich, Patrick Y Wen, et al.
Neuro-Oncology
|
January 25, 2020
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients
Eudocia Q Lee, Michael Weller, Joohee Sul, et al.
Page
of 9